>It seems like half a lifetime ago that IDIX was my biggest-ever biotech mistake. Instead, it’s turned into one of my biggest successes.<
You gotta admit though that this one was more luck than anything else. The HepB drug has not been responsible for the price move, and the HepC candidate that was the other attractive piece isn't even around anymore.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.